Alterity Therapeutics Ltd News

Alterity Therapeutics Ltd: Appendix 4E Preliminary Final Report

Aug 28 23:23 ET

Alterity Therapeutics Ltd: Notification of cessation of securities - ATH

Jul 31 18:35 ET

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 18:12 ET

Alterity Therapeutics Ltd: Alterity Therapeutics to Present at MST Financial Webinar

Jul 23 21:15 ET

Alterity Therapeutics Ltd: Notice Under Section 708A

Jul 18 22:19 ET

Alterity Therapeutics Ltd: Application for quotation of securities - ATH

Jul 18 22:17 ET

Alterity Therapeutics Ltd: Proposed issue of securities - ATH

Jul 17 22:16 ET

Alterity Therapeutics Ltd: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial

Jul 16 20:20 ET

Alterity Therapeutics Ltd: Trading Halt

Jul 14 19:25 ET

Alterity Therapeutics Ltd: Notification regarding unquoted securities - ATH

Jun 28 02:58 ET

Alterity Therapeutics Ltd: Alterity to Present at Hidden Gems in Life Sciences Webinar

Jun 12 18:42 ET

Alterity Therapeutics Ltd: Webcast Today - New Data from bioMUSE Natural History Study

May 29 18:39 ET

Alterity Therapeutics Ltd: Notification of cessation of securities - ATH

May 21 01:19 ET

Alterity Therapeutics Ltd: Phase 2 DMC Recommends Continuing Clinical Trial as Planned

May 7 18:27 ET

Alterity Therapeutics Ltd: Ceasing to be a substantial holder

May 7 18:20 ET

Alterity Therapeutics Ltd: Change in substantial holding

May 2 18:23 ET

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 19:06 ET

Alterity Therapeutics Ltd: Application for quotation of securities - ATH

Apr 28 19:01 ET

Alterity Therapeutics Ltd: Alterity Presents New Data on ATH434

Apr 28 18:41 ET

Alterity Therapeutics Ltd: Change in substantial holding

Apr 17 18:24 ET